Purpose To find out what is known from literature about Long COVID until January 30, 2021.
Methods We undertook a four-step search with no language restriction. A preliminary search …

Though the acute effects of SARS-CoV-2 infection have been extensively reported, the long-
term effects are less well described. Specifically, while clinicians endure to battle COVID-19 …

Background and purpose Neurological complications of SARS‐CoV‐2 infection are noticed
among critically ill patients soon after disease onset. Information on delayed neurological …

Psychotic symptoms have been related to other coronavirus infections. We conducted a
single-centre retrospective and observational study to describe new-onset psychotic …

The binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike
glycoprotein to its cellular receptor, the angiotensin-converting enzyme 2 (ACE2), causes its …

Introduction It is known that viral infections are epidemiologically prevalent and some of
them are harmful to the central nervous system (CNS) due to the development of …

Background Series of patients with SARS‐CoV‐2 infection report headache in 6%‐15% of
cases, although some data suggest that the actual frequency is higher, and that headache is …

Background Cognitive manifestations associated with Severe Acute Respiratory Syndrome
by Coronavirus 2 (SARS-CoV-2) are yet to be described in the existing literature. The aim of …

The novel coronavirus (2019-nCoVCOVID-19) belongs to the Beta coronavirus family, which
contains MERS-CoV (Middle East respiratory syndrome coronavirus) and SARS-CoV …

Introducción: La COVID-19, enfermedad provocada por el nuevo coronavirus SRAS-CoV 2,
afecta a la humanidad desde finales de 2019, y en pocos meses alcanzó la categoría de …